The latest in precision prevention news, curated for CancerIQ's community of oncologists, genetic counselors, breast centers, primary care providers, and anyone interested in staying ahead of cancer.
- Announcing CancerIQ for Preventive Care
"They say HLTH is where the future of health happens. And yesterday, Candace Westgate and I got to share with the crowd in Vegas how CancerIQ is making the future of precision cancer prevention possible in preventive care.
CancerIQ’s expanded platform enables primary care providers to assess patients not only for genetic and hereditary cancer risk, but lifestyle and adherence risk as well. That way, each patient who walks through the door can receive a hyper-personalized cancer prevention plan.
We’re inviting forward-thinking hospitals and health systems to step into the future of precision cancer prevention with us. Join seven other health systems in the PREVENT initiative to measure the clinical and financial impact of our expanded platform and work to end cancer as we know it." – Feyi Olopade Ayodele, CEO via LinkedIn - Ovarian Cancer Survivor: Learning about BRCA Saved My Life via UPenn Medicine
"Orthey decided to have genetic testing and counseling, which confirmed that she had a BRCA2 mutation. Although she quickly decided to have preventive surgery, she was focused on helping her sister through cancer treatment and put off scheduling her own procedures.
In June 2014, Orthey came to Penn Medicine for a prophylactic double mastectomy and oophorectomy. The eight-hour surgery removed her breasts and ovaries with the goal of preventing cancer in the future, so Orthey was surprised when the surgery ended up revealing she had ovarian cancer. She hadn’t noticed any symptoms... Although Orthey’s doctors confirmed that her surgeries had removed all visible signs of cancer, they still recommended chemotherapy.My original motivation for the prophylactic surgeries was to avoid having to go through cancer and chemotherapy someday,” said Orthey. “But when the doctor explained that chemo would reduce the chance any single microscopic cells that might have escaped surgery could grow somewhere else, I knew it was worth it.”
- Breast Cancer Awareness Month: How digital health is improving breast cancer screening and care via mdisrupt
"The CDC recommends that women with an average risk profile start breast cancer screenings at the age of 40. But how does a person know if they have an average risk profile? Enter: CancerIQ. Their software provides customized screening recommendations based upon each individual’s genetics, family history, lifestyle, and comorbidities. I’m excited about this product because it improves how healthcare resources are allocated and works towards patients getting the right screening at the right time for them."
- Why now is the time for inclusive health investment via Fierce Healthcare
We also champion investing in digital health because of the impact digital solutions can make on traditionally underrepresented populations. For instance, Black women are more likely to be diagnosed with advanced-stage breast cancer and more likely to die of the disease than white women. CancerIQ, a digital health company in our portfolio, is built to prevent cancer or detect it early by ensuring all women are properly risk-assessed and screened for the disease. - Letter From the CEO: Gratitude Edition
I always enjoy spending time out in the field, surrounded by the people working to advance access to precision cancer prevention. And after the last two years, that time is more meaningful than ever.
That’s exactly why I – and the CancerIQ team – headed to HLTH 2022 in Las Vegas, the NSGC Annual Conference in Nashville, and the AACR Special Conference in Austin, Texas.
I’m grateful we got to share new efforts from CancerIQ to make the work of early cancer identification and prevention at scale more realistic.
- How a Wrong Diagnosis Masked a Young Woman's Cancer via Medscape
Two years ago, then 28-year-old Ashley Teague began losing weight. At the time, the Indianapolis, IN, native and mother of two was 6-foot-1 and weighed about 270 pounds.
Teague's 56-year-old mother was also a patient at the same medical practice where she was being treated. After being diagnosed with kidney cancer at 38 and then breast cancer at 52, the two-time cancer survivor underwent genetic testing and found out she had Lynch syndrome, which is a genetic disorder caused by a mutation in a gene. It increases the risk of various types of cancer.
Teague says she told her providers that her mother had Lynch syndrome, but they never suggested she be tested for the disorder.
___________
Don't wait until the end of the month for stories like these. Stay up-to-date with the latest in precision prevention news. Follow CancerIQ on social media to be the first to see our curated content on cancer prevention, precision medicine & oncology, health equity, and more.
Follow Cancer IQ on Social Media
